BEGIN:VCALENDAR VERSION:2.0 PRODID:-//The Male Breast Cancer Global Alliance - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:The Male Breast Cancer Global Alliance X-ORIGINAL-URL:https://mbcglobalalliance.org X-WR-CALDESC:Events for The Male Breast Cancer Global Alliance REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20210314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20211107T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20241102T093000 DTEND;TZID=America/New_York:20241102T180000 DTSTAMP:20260417T143346 CREATED:20240924T193756Z LAST-MODIFIED:20241102T175359Z UID:5859-1730539800-1730570400@mbcglobalalliance.org SUMMARY:MBCGA Annual Conference DESCRIPTION:The Annual Male Breast Cancer Global Alliance Virtual Conference connects male survivors\, their families\, friends and supporters with top medical professionals and leading experts from the breast cancer research and oncology fields. The international conference\, which focuses on increasing awareness and education about breast cancer in men\, showcases the latest in research developments and clinical trials with an impressive line-up of speakers from leading organizations around the world. \n \n Register\n \n \n Conference schedule\n \n2024 CONFERENCE SPEAKERS\n\n \nJosé Pablo Leone\, MD\, Director\, Program for Breast Cancer in MenAssistant Professor of Medicine\, Harvard Medical School\, Dana-Farber Cancer Institute\, Boston\, MA \nDr. Leone’s clinical research focuses on brain metastases\, male breast cancer and novel therapies in the treatment of breast cancer; he has co-authored 58 peer-reviewed articles and participated in 3 clinical trials in the past 15 years. \nRead More \n \nKara N. Maxwell\, MD\, PhD\, Assistant Professor of Medicine & Genetics\, Perelman School of Medicine\, University of Pennsylvania; Staff Physician\, Corporal Michael Crescenz VA Medical Center\, Philadelphia\, PA \nDr. Maxwell is the Director of the Men and BRCA Program within the Basser Center for BRCA at Penn Medicine and also the Director of the Cancer Genetics program at the Philadelphia VA. Her laboratory studies mechanisms of tumor formation in patients with inherited forms of breast and prostate cancer. \nRead more \n \nHarikrishna Nakshatri\, BVSc\, PhD; Marion J. Morrison Professor of Breast Cancer Research\, Professor of Surgery\, Biochemistry and Molecular Biology\, Indiana University School of Medicine; Associate Director of Education and Co-Leader\, Breast Cancer Working Group\, Indiana University Simon Comprehensive Cancer Center. Indianapolis\, IN  \nDr. Nakshatri studies the molecular drivers of therapy resistance in breast cancer. His group has developed various model systems to study breast cancer initiation and progression in both women and men. \nRead more \n \nProfessor Nick Orr\, PhD; School of Medicine\, Dentistry and Biomedical Sciences\, Patrick G. Johnston Centre for Cancer Research at Queen’s University\, Belfast\, Ireland \nProfessor Orr is the Lead Researcher of an international consortium working to uncover genes that lead to breast cancer in men. The consortium\, known as MERGE\, is focusing on discovering and characterizing new genetic risk factors for male breast cancer by analyzing DNA from 5\,000 men. \nRead more \n \nBen H. Park\, MD\, PhD; Benjamin F. Byrd\, Jr. Chair in Oncology; Director\, Vanderbilt-Ingram Cancer Center; Professor of Medicine\, Vanderbilt University Medical Center in Nashville\, TN \nDr. Park is an internationally-renowned physician\, scientist\, and breast cancer expert with a specialty in male breast cancer research and clinical care of men with breast cancer. He has published widely on the genetics of male breast cancer as well as reviews regarding the clinical management of men with this disease. \nRead more \n \nKathryn Ruddy\, MD\, Professor of Oncology (with a specialty in male breast cancer) and Consultant for the Division of Medical Oncology at the Mayo Clinic in Rochester\, MN \nDr. Ruddy is a medical oncologist who specializes in breast cancer patients. She has special expertise in male breast cancer and studies the long-term and late effects of cancer treatments\, and how best to care for cancer survivors to enhance their quality of life and reduce symptoms. \nRead more \n \nCarolien Schröder\, MD\, PhD\, Staff Member\, Medical Oncology\, Department\, Antoni Van Leeuwenhoek-Netherlands Cancer Institute in Amsterdam\, The Netherlands \nDr. Schröder’s research is focused on pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases\, early clinical trials with novel anticancer agents\, and large-scale registration and translational trials for rare subgroups including male and inflammatory breast cancer. \nRead more \n \nAnder Urruticorchea\, MD\, PhD\, Institute Scientific and General Manager\, Onkologikoa Foundation\, San Sebastián\, Spain; Associate Professor\, Faculty of Health Sciences\, University of Deusto in Bilbao\, Spain \nDr. Urruticorchea is Medical Oncology Specialist whose research focuses on molecular biology and the treatment of breast cancer\, with a particular focus on endocrine resistance. He is Vice Chair of GEICAM (The Spanish Breast Cancer Group)\, where he co-leads the Spanish Registry of Male Breast Cancer. \nRead more \nALL are welcome to attend our 2024 MBCGA Virtual Conference free of charge. However\, your donation (no amount is too small!) will help us to continue increasing awareness and providing the most up-to-date information on breast cancer in men\, advances in research and treatments\, seek out opportunities for clinical trials\, and advocate for treatment equity\, on a global scale. Thank you for your support! \n \n Register\n \n \n Donate\n \nThank you to our 2024 MBCGA Virtual Conference sponsors. URL:https://mbcglobalalliance.org/event/mbcga-annual-conference-2024/ ATTACH;FMTTYPE=image/png:https://mbcglobalalliance.org/wp-content/uploads/2022/07/2024-MBCGA-Conference-Homepage-Tile-Image-REV.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231104T093000 DTEND;TZID=America/New_York:20231104T180000 DTSTAMP:20260417T143346 CREATED:20230816T114902Z LAST-MODIFIED:20231101T221026Z UID:4449-1699090200-1699120800@mbcglobalalliance.org SUMMARY:MBCGA Annual Conference DESCRIPTION:The Annual Male Breast Cancer Global Alliance Conference brings together male survivors\, their families\, friends and supporters with top medical professionals and leading experts from the breast cancer research and oncology fields. The international conference\, which focuses on increasing awareness and education about breast cancer in men\, showcases the latest in research developments and clinical trials with an impressive line-up of speakers from leading organizations around the world. Join us for this “virtual” day of sharing\, learning and camaraderie! \n \n Register\n \nMBCGA 2023 CONFERENCE SPEAKERS\n\n \nOliver Bogler\, PhD\, Breast Cancer Survivor\, Director\, NCI Center for Cancer Training inBethesda\, MD \nDr. Bogler was diagnosed with Stage III cancer in 2012 while working as a cancer biologist at the University of Texas MD Anderson Cancer Center. He completed active treatment in 2013 and has participated in several clinical trials. Dr. Bogler is currently the Director of the Center for Cancer Training at the National Cancer Institute (NCI) in Bethesda\, MD. \nRead more \n \nFatima Cardoso\, MD\, Director\, Breast Unit\, Champalimaud Clinical Center in Lisbon\, Portugal \nDr. Cardoso is actively involved in many Stage I-IV breast cancer clinical trials and is deeply involved in the field of cancer policy\, accessibility\, and inequalities. She is the Founder and President of the Advanced Breast Cancer (ABC) Global Alliance\, as well as the Founder and Chair of the ABC International Consensus Guidelines Conference.  \nRead more \n \nSharon Giordano\, MD\, MPH\, FASCO\, Colin Powell Chair for Cancer Research; Chair\, Department of Health Services Research; Professor of Medicine\, Department of Breast Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston\, TX \nDr. Giordano is a medical oncologist specializing in the care of patients with breast cancer. Her work focuses on quality of health care delivery\, disparities\, outcomes for breast cancer patients\, late effects of treatment\, and male breast cancer. \nRead more \n \nJosé Pablo Leone\, MD\, Director\, Program for Breast Cancer in MenAssistant Professor of Medicine\, Harvard Medical School\, Dana-Farber Cancer Institute\, Boston\, MA \nDr. Leone’s clinical research focuses on brain metastases\, male breast cancer and novel therapies in the treatment of breast cancer; he has co-authored 58 peer-reviewed articles and participated in 3 clinical trials in the past 15 years. \nRead more \n \nKara N. Maxwell\, MD\, PhD\, Assistant Professor of Medicine & Genetics\, Perelman School of Medicine\, University of Pennsylvania; Staff Physician\, Corporal Michael Crescenz VA Medical Center\, Philadelphia\, PA \n Dr. Maxwell is the Director of the Men and BRCA Program within the Basser Center for BRCA at Penn Medicine and also the Director of the Cancer Genetics program at the Philadelphia VA.  \nRead more \n \nIngrid A. Mayer\, MD\, MSCI; Vice President\, Global Clinical Strategy Head – Women’s Cancers\, AstraZeneca Late Development Oncology\, Gaithersburg\, Maryland \nDr. Mayer’s role is to pioneer and expand novel translational global research and innovative clinical trial development in breast cancer that accelerates the approval of established and novel drugs in the key areas of excellence at AstraZeneca\, tumor resistance/targeted therapies\, DNA damage response\, antibody-drug conjugates\, and immuno-oncology.  \nRead more \n \nDr. Nick Orr\, PhD\, School of Medicine\, Dentistry and Biomedical Sciences\, Patrick G. Johnston Centre for Cancer Research at Queen’s University in Belfast\, Ireland \nDr. Orr is the Lead Researcher for a new international consortium working to uncover genes that lead to breast cancer in men. \nRead more \n \nBen H. Park\, MD\, PhD\, Director\, Vanderbilt-Ingram Cancer Center\, Cornelius Abernathy Craig Chair\, Professor of Medicine\, Division of Hematology/Oncology\, Vanderbilt University Medical Center in Nashville\, TN \nDr. Park is an internationally renowned physician\, scientist\, and breast cancer expert with a specialty in male breast cancer research and clinical care of men with breast cancer. \nRead more \n \nCarolien Schröder\, MD\, PhD\, Staff Member\, Medical Oncology\, Department\, Antoni Van Leeuwenhoek-Netherlands Cancer Institute\, Amsterdam\, The Netherlands \nDr. Schröder’s research is focused on pre-clinical and clinical intervention strategies directed at the breast cancer microenvironment and metastases\, early clinical trials with novel anticancer agents\, and large-scale registration and translational trials for rare subgroups including male and inflammatory breast cancer. \nRead more \n \nMatthew Ellis\, MD\, BChir\, PhD\, FRCP\, Senior Vice President\, Early Oncology\, Oncology R&D\, AstraZeneca. \nDr. Ellis is a world-renowned clinician and researcher of the molecular profiling of breast cancer who leads a global community of over 1000 scientists working to bring the next wave of oncology medicines from target identification and into the clinic. \nRead more \n \n Download the 2023 MBCGA Conference Agenda & Schedule\n \nALL are welcome to attend our 2023 MBCGA Virtual Conference free of charge. However\, your donation (no amount is too small!) will help us to continue increasing awareness and providing the most up-to-date information on breast cancer in men\, advances in research and treatments\, and opportunities for clinical trials\, on a global scale. Thank you for your support! \n\n\n\n \n \n \n \n \n \n \n \n \n\n\n\nThank you to our 2023 MBCGA Virtual Conference sponsors. URL:https://mbcglobalalliance.org/event/mbcga-annual-conference-virtual-saturday-november-4/ ATTACH;FMTTYPE=image/png:https://mbcglobalalliance.org/wp-content/uploads/2023/08/MBCGA-Conference-Landing-Page-Image-copy.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20221020T100000 DTEND;TZID=America/New_York:20221020T180000 DTSTAMP:20260417T143346 CREATED:20220723T133317Z LAST-MODIFIED:20221110T233427Z UID:1948-1666260000-1666288800@mbcglobalalliance.org SUMMARY:MBCGA Annual Conference DESCRIPTION:The Annual Male Breast Cancer Global Alliance Conference brings together male survivors\, their families\, friends and supporters for a “virtual” day of sharing\, learning and camaraderie. Medical professionals and organizations from all over the world also participate to impart the latest information on research and clinical trials\, and answer questions one-on-one. The conference\, which focuses on increasing awareness and education about breast cancer in men\, offers an impressive line-up of speakers (still in formation) including top medical professionals and leading experts from the breast cancer research and oncology fields. \n2022 Conference Speakers:\n \nJohn Boyages\, AM\, Radiation Oncologist\, Icon Cancer Centre Sydney Adventist Hospital; Chair\, Icon National Breast Interest Group; Professor of Medicine\, ANU Medical School\, ANU College of Health and Medicine; Honorary Professor and Found Director\, ALERT Lymphodema Program; Author\, Taking Control series of patient books on breast cancer\, male breast cancer\, DCIS\, and cancer & vaccinations (Sydney\, Australia) \nRead more \n \nBen H. Park\, MD\, PhD\, Professor of Medicine\, Associate Director for Translational Research\, Co-Leader Breast Cancer Program\, and Director for Precision Oncology at Vanderbilt University Medical Center (Nashville\, TN) \nRead more \n \n David Brenin\, MD\, FACS\, M.C. Wilhelm Professor in Diseases of the Breast and Chief of the Division of Breast and Melanoma Surgery\, in the department of surgery at The University of Virginia School of Medicine  (Charlottesville\, Virginia)\n\nRead more\nDavid R. Brenin\, MD\, FACS – 2022 MBCGA Conference Presentation\n \nJosé Pablo Leone\, MD\, Director for Breast Cancer in Men at Dana-Farber Cancer Institute (Boston\, MA) and Assistant Professor of Medicine\, Harvard Medical School \nRead more \n \nKathryn J. Ruddy\, MD\, Professor of Oncology (with a specialty in male breast cancer) and Consultant for the Division of Medical Oncology at the Mayo Clinic (Rochester\, MN) \nRead more \nBreakout sessions will also be part of the agenda\, providing opportunities for moderated discussions on key topics including Metastatic Breast Cancer\, Genetics & Male Breast Cancer\, Caregivers\, and Managing Treatment Side Effects. \nALL are welcome to attend our 2022 MBCGA Virtual Conference free of charge. However\, we would be extremely grateful if you would consider making a donation (no amount is too small!) to help us continue bringing you the most up-to-date information on breast cancer in men\, advances in research and treatments\, and opportunities for clinical trials. Thank you—in advance—for your support! \n \n Register\n \n \n\n\n \n \n \n \n \n \n \n \n \n\n\n \nWe invite you to become an MBCGA Conference Sponsor\nAs an MBCGA Conference Sponsor\, your support will help us continue providing help and support to those who have been diagnosed. Our Annual Conference is an integral part of our ongoing efforts to provide education\, support and opportunities for men with breast cancer\, and their families and caregivers\, to connect with others who have experienced the “male breast cancer journey\,” and interact with medical professionals and researchers from all over the world. \nDownload our 2022 Annual Conference Sponsorship Brochure for more information on how YOU can help! URL:https://mbcglobalalliance.org/event/mbcga-annual-conference/ ATTACH;FMTTYPE=image/jpeg:https://mbcglobalalliance.org/wp-content/uploads/2022/07/MBCGA-Conference-Landing-Page-Image-with-border.jpg END:VEVENT END:VCALENDAR